2025 Year in Review | Advancing Science, Strengthening Partnerships

Flow Chemistry @ Piramal Pharma Solutions- explained by Narendra Ambhaikar, India API Technical Lead

Chromatography: A Versatile Tool for Solving Purification Challenges

Piramal Pharma Solutions: Your Trusted Global CDMO Partner for End-to-End API Success

Every Step, Every Story, Every Site —Driven by Patients. Patient Centricity Week Celebrations.

6 Reasons to Partner with Piramal Aurora on APIs

Expanding Our Facility and Strengthening Our Workforce

The Role of Quality in Our Commercial Scale Facility Expansion

Stu Needleman, CCO and Chief Patient Centricity Officer Explores How Our Expansion Benefits Patients

Understanding Our $85M Facility Expansion with COO, Herve Berdou

Expanding Operations Onshore in North America

Inside Our $85M Facility Expansion with Site Head, Nathan Richardson

Breaking Ground on Our $85 Million Sterile Injectable Facility Expansion

Launching an $85M Expansion at Our Sterile Injectables Facility

Meet Our Site Head Vishwanath Nande, Ahmedabad PPDS India Site

Piramal Pharma Solutions Featured on the Weekly Team Kentucky Update with Governor Andy Beshear

Patient Centricity Tree at Riverview, USA Site

Meet Our Site Head Vishwanath Nande of Ahmedabad PPDS India Explaining about Site Capabilities

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Meet Our Site Head Dr. Gajendrasinh Raolji, Site Head Ahmedabad, India Discovery Solutions Site.

Meet our Site Head Nathan Richardson, Associate Vice President and Site Head, Lexington, USA

Piramal Pharma announces $85M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky

Meet Our Science Collective Sundar “Sunny” Neelakantan, M.S., Ph.D. Director of Development.

Meet Conor Barry, Global Head of Bioconjugates Development from our Science Collective.

Meet our Site Head Francois Houbart, Managing Director of our ADC Facility in Grangemouth, Scotland.

Meet Jean-Francois Carniaux (JF), VP and Global API Technical Lead from our Science Collective.

Piramal Pharma Solutions: Grangemouth, UK

Company Spotlight with Pharmaceutical Technology

The Voice of Patient Centricity

Meet Thomas B. (Brad) Gold, Ph.D.Head, Global Formulations R&D from our Science Collective.

Antibody Drug Conjugation Services, Grangemouth, Scotland

Piramal Pharma Solutions Operational Excellence

Piramal Pharma Solutions Capabilities Review

Piramal Pharmas Associate Company Yapan Bio Pvt Ltd.

Piramal Pharma Solutions Position on East and West Offerings

PPS Transition to On Patent Work and Value to the Customer

PPS Transition to Differentiated Offerings and Value to the Customer

PPS Transition to Integrated Projects and Value to the Customer

Piramal Pharma Solutions Program Management

Meet our Site Head Don Liscombe, Vice President and Site Head of our API facility in Aurora, Canada.

Cabinet Secretary Màiri McAllan MSP visits our ADC facility in Grangemouth, Scotland, UK.

Piramal Pharma Limited Approach to ESG

Piramal Pharma Limited Approach to Cyber Security

Piramal Pharma Limited Approach to Environment Health & Safety (EHS)

Grand Opening of our ADC Manufacturing Expansion in Grangemouth, Scotland, Dec 18, 2023.

Recent Updates and Future Plans for Piramal Pharma Solutions

Transition to Differentiated Offerings and Value to Consumer

Approach to Customer Centricity by Peter DeYoung, CEO, Piramal Pharma Solutions

Patient Centricity @ Piramal Pharma Solutions

Piramal Pharma Solutions- V Block, Pithampur, India

PPS 2022 Wrap up Video

Expansion and Upgrade of our Grangemouth, UK Facility

Piramal Pharma Solutions Demerger explained by Peter DeYoung, CEO, Piramal Global Pharma

Introduction to Piramal Pharma Solutions

Stu Needleman, Chief Patient Centricity Officer, and CCO talks about Patient Centricity

PPS Holds Grand Opening Ceremony for New API Plant at Aurora, Canada Manufacturing Site

PPS strengthens UK Presence with the Expansion and Upgrade of its Grangemouth and Morpeth Facilities

PPS 2021 Wrap up Video

Dedicated Dialogue: The Integrated Approach to Drug Development and Manufacturing

Application of DOE Design of Experiments to Antibody Drug Conjugates ADC Process Development